Skip to main content

Filter press releases

Start date
End date
Business
Showing 11 - 20 of 6422 results within GE Newsroom

GE ANNOUNCES FIRST QUARTER 2020 RESULTS

April 29, 2020
COVID-19 challenged first-quarter results; taking swift action to mitigate impact and solidify financial position Total orders $19.5B, (5)%; organic orders (3)% Total revenues (GAAP) $20.5B, (8)%;…

GE Announces Expiration and Results of its Debt Tender Offers

April 21, 2020
BOSTON – April 21, 2020 – GE (NYSE:GE) today announced the expiration and results of its previously announced offers to purchase for cash: (1) any and all of the U.S. Dollar Denominated, Euro…

GE Announces Debt Tender Offers

April 13, 2020
GE Announces Offers to Purchase (1) Any and All of Certain of its Outstanding U.S. Dollar Denominated, GBP Denominated and Euro Denominated Notes (Listed on Table I Below), originally issued by its…

GE Announces Further Actions to Solidify Financial Position

April 13, 2020
BOSTON — April 13, 2020 — GE (NYSE:GE) today announced a series of further actions it is taking to solidify its financial position: In order to extend its Industrial debt maturities and enhance its…

GE Provides Updates on Guidance and First Quarter

April 09, 2020
GE withdraws financial guidance due to uncertainty associated with COVID-19 Preliminary view of first-quarter results indicates adjusted EPS* materially below prior guidance of about $0.10;…

GE Announces Completion of BioPharma Sale to Danaher, Receives $20 Billion Net Cash Proceeds

March 31, 2020
BOSTON, Mass.—March 31, 2020—GE (NYSE:GE) announced today the completion of the sale of its BioPharma business to Danaher Corporation (NYSE:DHR) (“Danaher”) for approximately $20 billion of net…

An Update on the Challenge of COVID-19

March 23, 2020
BOSTON, Mass.—March 23, 2020—GE (NYSE:GE) Chairman and CEO H. Lawrence Culp, Jr., today issued the following message to GE employees:   Team,   As COVID-19 continues to spread, the leadership team…

GE and Danaher Satisfy All Required Regulatory Clearances for BioPharma Transaction; Expect to Close on March 31, 2020

March 19, 2020
BOSTON, Mass.—March 19, 2020—GE (NYSE:GE) announced that, together with Danaher Corporation (NYSE:DHR) (“Danaher”), it has entered into a consent decree agreement with the U.S. Federal Trade…

Déclaration du PDG de GE Healthcare sur les efforts déployés pour lutter contre le coronavirus

March 19, 2020
CHICAGO – 19 mars, 2020 – Kieran Murphy, Président et Directeur général de GE Healthcare, a fait la déclaration suivante sur les efforts déployés pour lutter contre le coronavirus (COVID-19) : GE…

Egalité Femmes-Hommes : résultats en progression chez GE en France

March 09, 2020
9 Mars, 2020 Les entités légales du groupe GE en France ont publié des résultats en progression en 2019 au titre de l’Index de mesure de l'égalité professionnelle entre les femmes et les hommes.…